IPG Photonics Shares Plunge on Weak Q2 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy IPGP?
Source: seekingalpha
IPG Photonics Corp shares fell 21.98% as the stock crossed below its 5-day SMA, reflecting investor concerns over its weak Q2 outlook. The company forecasts Q2 sales between $260 million and $290 million, which is below the $275.75 million estimate, indicating challenges in market demand. Additionally, adjusted gross margins are expected to be between 37% and 40%, raising worries about profitability. Despite a strong Q1 performance, the mixed results and the patent litigation settlement with TRUMPF do little to alleviate market fears about future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IPGP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IPGP
Wall Street analysts forecast IPGP stock price to fall
4 Analyst Rating
2 Buy
1 Hold
1 Sell
Hold
Current: 101.940
Low
77.50
Averages
95.83
High
110.00
Current: 101.940
Low
77.50
Averages
95.83
High
110.00
About IPGP
IPG Photonics Corporation develops, manufactures, and sells fiber lasers, fiber amplifiers, diode lasers and laser-based systems. It designs and manufactures components used in its finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers and complementary products. The Company’s portfolio of laser solutions is used in materials processing, medical, advanced applications and communications, among others. It also manufactures and sells complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors and chillers. Its products include Continuous Wave (CW) lasers (1-125 kW) and IPG systems, Nanosecond (NS) pulsed lasers (100-3,000 W), Infrared (IR), green and ultraviolet (UV) pulsed lasers, Picosecond (PS), and Femtosecond (FS) pulsed lasers. It also makes direct diode lasers, packaged semiconductor diodes, laser and non-laser systems and laser-based medical systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IPG Photonics Q1 2026 Earnings Call Insights
- Significant Revenue Growth: IPG Photonics reported total revenue of $265 million in Q1 2026, reflecting a 17% year-over-year increase, indicating sustained demand for laser solutions in battery manufacturing and medical applications, thereby enhancing the company's competitive position in these markets.
- Industrial Solutions Dominance: Industrial Solutions accounted for 86% of total sales in Q1, growing 21% year-over-year, primarily driven by applications in welding, cutting, marking, and cleaning, with sequential performance remaining flat yet outperforming typical seasonality, showcasing the company's robust performance in the industrial sector.
- CROSSBOW Order Progress: The company secured a $10 million follow-on order from Lockheed Martin in February, with shipments expected to commence in Q2, which not only provides revenue assurance for the future but also strengthens the partnership with a key customer.
- Cautious Future Outlook: Management anticipates Q2 revenue between $260 million and $290 million, with adjusted earnings per share projected at $0.25 to $0.55; despite facing tariff pressures, the company remains committed to enhancing profitability through cost control and pricing strategies.
See More
Key Wall Street Rating Changes Overview
- LCI Industries Upgrade: Roth upgrades LCI Industries from Hold to Buy with a price target of $164, unchanged, following outsized Q1 EPS, indicating strong profitability that is expected to drive stock price upward.
- VF Corp Upgrade: BTIG raises VF Corp's rating from Neutral to Buy, citing more reasonable estimates reflecting positive outlook for Vans brand, which could enhance market confidence and shareholder returns.
- DaVita's Strong Performance: Deutsche Bank upgrades DaVita from Hold to Buy after reporting Q1 revenues of $3.415 billion, beating consensus by 2.2%, and EPS of $2.87, exceeding expectations by 22.1%, showcasing robust treatment growth and revenue per treatment.
- Monster Beverage Upgrade: Rothschild & Co Redburn upgrades Monster Beverage from Neutral to Buy, highlighting significant international growth potential as the company currently holds only 14% market share, suggesting substantial future market position improvement.
See More
IPG Photonics Shares Enter Oversold Territory
- Oversold Signal: IPG Photonics shares fell to $86 on Tuesday, resulting in an RSI of 29.0, indicating that the recent heavy selling pressure may be waning, thus presenting potential buying opportunities for investors.
- Market Comparison: In contrast, the current RSI of the S&P 500 ETF (SPY) stands at 71.6, suggesting that the broader market remains strong, which further highlights the oversold condition of IPGP.
- Historical Performance: IPGP's 52-week low is $51.77 and its high is $155.82, with the last trade at $90.84, showcasing significant price volatility that may attract investors looking for a rebound.
- Investor Sentiment: While the stock is currently in oversold territory, investors should carefully assess market sentiment and technical indicators to determine whether to enter at this time, avoiding potential further downside risks.
See More
IPG Photonics Q1 Earnings Beat Expectations but Stock Plummets
- Earnings Beat: IPG Photonics reported Q1 earnings of $0.29 per share, surpassing analyst expectations of $0.27, with sales reaching $265.5 million, reflecting a robust 17% year-over-year growth despite market challenges.
- Profitability Decline: Despite the sales increase, IPG's gross margin fell to 37.5%, resulting in an operating loss, with GAAP net profit at only $0.04 per share, over 50% lower than last year's Q1, highlighting the impact of tariff costs on profitability.
- Severe Market Reaction: Following the disappointing future profit outlook, IPG's stock plummeted by 24.8%, trading at a high P/E ratio of 167, indicating that investor confidence in future growth has been shaken, leading to a sell-off.
- Cautious Future Outlook: Management forecasts Q2 sales between $260 million and $290 million, with slight gross margin improvement; however, the market expected a profit of $0.43 per share, while the midpoint of their range is only $0.40, suggesting a potential small miss on expectations.
See More
IPG Photonics Shares Plunge 14% on Weak Q2 Outlook
- Weak Earnings Outlook: IPG Photonics forecasts Q2 sales between $260 million and $290 million, with the midpoint slightly below the $275.75 million estimate, indicating challenges in market demand.
- Declining Margin Expectations: The company anticipates adjusted gross margins of 37% to 40%, reflecting potential cost pressures that could impact profitability and heighten investor concerns.
- Mixed Quarterly Results: While Q1 revenue reached $265.5 million, exceeding the $257 million estimate, adjusted earnings per share of $0.29 fell short of the $0.31 expectation, highlighting volatility in earnings performance.
- Patent Litigation Settlement: IPG announced a settlement with TRUMPF Laser- und Systemtechnik SE regarding patent litigation, which may alleviate legal risks but fails to assuage market worries about future performance.
See More
IPG Photonics Q1 Earnings Beat Expectations
- Earnings Highlights: IPG Photonics reported a Q1 non-GAAP EPS of $0.29, missing estimates by $0.02, while revenue reached $265.5 million, reflecting a 16.5% year-over-year increase and exceeding expectations by $8.56 million, indicating strong market performance.
- Future Outlook: The company anticipates Q2 2026 revenue between $260 million and $290 million, below the $275.75 million consensus, with adjusted gross margins expected between 37% and 40%, reflecting a cautious approach to future growth.
- Cost Management: IPG expects adjusted operating expenses to range from $92 million to $95 million, indicating efforts to control costs while expanding, which is crucial for maintaining profitability.
- Earnings Projections: The company forecasts adjusted earnings per diluted share between $0.25 and $0.55, below the consensus of $0.43, with adjusted EBITDA expected between $32 million and $48 million, highlighting uncertainty in future profitability.
See More
IPG Photonics Q1 2026 Earnings Call Insights
- Significant Revenue Growth: IPG Photonics reported total revenue of $265 million in Q1 2026, reflecting a 17% year-over-year increase, indicating sustained demand for laser solutions in battery manufacturing and medical applications, thereby enhancing the company's competitive position in these markets.
- Industrial Solutions Dominance: Industrial Solutions accounted for 86% of total sales in Q1, growing 21% year-over-year, primarily driven by applications in welding, cutting, marking, and cleaning, with sequential performance remaining flat yet outperforming typical seasonality, showcasing the company's robust performance in the industrial sector.
- CROSSBOW Order Progress: The company secured a $10 million follow-on order from Lockheed Martin in February, with shipments expected to commence in Q2, which not only provides revenue assurance for the future but also strengthens the partnership with a key customer.
- Cautious Future Outlook: Management anticipates Q2 revenue between $260 million and $290 million, with adjusted earnings per share projected at $0.25 to $0.55; despite facing tariff pressures, the company remains committed to enhancing profitability through cost control and pricing strategies.
See More
Key Wall Street Rating Changes Overview
- LCI Industries Upgrade: Roth upgrades LCI Industries from Hold to Buy with a price target of $164, unchanged, following outsized Q1 EPS, indicating strong profitability that is expected to drive stock price upward.
- VF Corp Upgrade: BTIG raises VF Corp's rating from Neutral to Buy, citing more reasonable estimates reflecting positive outlook for Vans brand, which could enhance market confidence and shareholder returns.
- DaVita's Strong Performance: Deutsche Bank upgrades DaVita from Hold to Buy after reporting Q1 revenues of $3.415 billion, beating consensus by 2.2%, and EPS of $2.87, exceeding expectations by 22.1%, showcasing robust treatment growth and revenue per treatment.
- Monster Beverage Upgrade: Rothschild & Co Redburn upgrades Monster Beverage from Neutral to Buy, highlighting significant international growth potential as the company currently holds only 14% market share, suggesting substantial future market position improvement.
See More
IPG Photonics Shares Enter Oversold Territory
- Oversold Signal: IPG Photonics shares fell to $86 on Tuesday, resulting in an RSI of 29.0, indicating that the recent heavy selling pressure may be waning, thus presenting potential buying opportunities for investors.
- Market Comparison: In contrast, the current RSI of the S&P 500 ETF (SPY) stands at 71.6, suggesting that the broader market remains strong, which further highlights the oversold condition of IPGP.
- Historical Performance: IPGP's 52-week low is $51.77 and its high is $155.82, with the last trade at $90.84, showcasing significant price volatility that may attract investors looking for a rebound.
- Investor Sentiment: While the stock is currently in oversold territory, investors should carefully assess market sentiment and technical indicators to determine whether to enter at this time, avoiding potential further downside risks.
See More
IPG Photonics Q1 Earnings Beat Expectations but Stock Plummets
- Earnings Beat: IPG Photonics reported Q1 earnings of $0.29 per share, surpassing analyst expectations of $0.27, with sales reaching $265.5 million, reflecting a robust 17% year-over-year growth despite market challenges.
- Profitability Decline: Despite the sales increase, IPG's gross margin fell to 37.5%, resulting in an operating loss, with GAAP net profit at only $0.04 per share, over 50% lower than last year's Q1, highlighting the impact of tariff costs on profitability.
- Severe Market Reaction: Following the disappointing future profit outlook, IPG's stock plummeted by 24.8%, trading at a high P/E ratio of 167, indicating that investor confidence in future growth has been shaken, leading to a sell-off.
- Cautious Future Outlook: Management forecasts Q2 sales between $260 million and $290 million, with slight gross margin improvement; however, the market expected a profit of $0.43 per share, while the midpoint of their range is only $0.40, suggesting a potential small miss on expectations.
See More
IPG Photonics Shares Plunge 14% on Weak Q2 Outlook
- Weak Earnings Outlook: IPG Photonics forecasts Q2 sales between $260 million and $290 million, with the midpoint slightly below the $275.75 million estimate, indicating challenges in market demand.
- Declining Margin Expectations: The company anticipates adjusted gross margins of 37% to 40%, reflecting potential cost pressures that could impact profitability and heighten investor concerns.
- Mixed Quarterly Results: While Q1 revenue reached $265.5 million, exceeding the $257 million estimate, adjusted earnings per share of $0.29 fell short of the $0.31 expectation, highlighting volatility in earnings performance.
- Patent Litigation Settlement: IPG announced a settlement with TRUMPF Laser- und Systemtechnik SE regarding patent litigation, which may alleviate legal risks but fails to assuage market worries about future performance.
See More
IPG Photonics Q1 Earnings Beat Expectations
- Earnings Highlights: IPG Photonics reported a Q1 non-GAAP EPS of $0.29, missing estimates by $0.02, while revenue reached $265.5 million, reflecting a 16.5% year-over-year increase and exceeding expectations by $8.56 million, indicating strong market performance.
- Future Outlook: The company anticipates Q2 2026 revenue between $260 million and $290 million, below the $275.75 million consensus, with adjusted gross margins expected between 37% and 40%, reflecting a cautious approach to future growth.
- Cost Management: IPG expects adjusted operating expenses to range from $92 million to $95 million, indicating efforts to control costs while expanding, which is crucial for maintaining profitability.
- Earnings Projections: The company forecasts adjusted earnings per diluted share between $0.25 and $0.55, below the consensus of $0.43, with adjusted EBITDA expected between $32 million and $48 million, highlighting uncertainty in future profitability.
See More
